{"id":"https://openalex.org/W3128097311","doi":"https://doi.org/10.3389/fphar.2020.633679","title":"Spider Venom Peptide Pn3a Inhibition of Primary Afferent High Voltage-Activated Calcium Channels","display_name":"Spider Venom Peptide Pn3a Inhibition of Primary Afferent High Voltage-Activated Calcium Channels","publication_year":2021,"publication_date":"2021-01-28","ids":{"openalex":"https://openalex.org/W3128097311","doi":"https://doi.org/10.3389/fphar.2020.633679","mag":"3128097311","pmid":"https://pubmed.ncbi.nlm.nih.gov/33584315","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7875911"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2020.633679","doi":"https://doi.org/10.3389/fphar.2020.633679","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2020.633679","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2020.633679/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2020.633679/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085347016","display_name":"Jeffrey R. McArthur","orcid":"https://orcid.org/0000-0002-2546-7913","observed_orcids":["https://orcid.org/0000-0002-2546-7913"]},"institutions":[{"id":"https://openalex.org/I204824540","display_name":"University of Wollongong","ror":"https://ror.org/00jtmb277","country_code":"AU","type":"education","lineage":["https://openalex.org/I204824540"]},{"id":"https://openalex.org/I4210091629","display_name":"Illawarra Health and Medical Research Institute","ror":"https://ror.org/00dt9qb91","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210091629"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Jeffrey R. McArthur","raw_affiliation_strings":["Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW, Australia","institution_ids":["https://openalex.org/I204824540","https://openalex.org/I4210091629"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025222461","display_name":"Nehan R. Munasinghe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Nehan R. Munasinghe","raw_affiliation_strings":["Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006227728","display_name":"Rocio K. Finol\u2010Urdaneta","orcid":"https://orcid.org/0000-0003-2157-4532","observed_orcids":["https://orcid.org/0000-0003-2157-4532"]},"institutions":[{"id":"https://openalex.org/I204824540","display_name":"University of Wollongong","ror":"https://ror.org/00jtmb277","country_code":"AU","type":"education","lineage":["https://openalex.org/I204824540"]},{"id":"https://openalex.org/I4210091629","display_name":"Illawarra Health and Medical Research Institute","ror":"https://ror.org/00dt9qb91","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210091629"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Rocio K. Finol-Urdaneta","raw_affiliation_strings":["Electrophysiology Facility for Cell Phenotyping and Drug Discovery, IHMRI, Wollongong, NSW, Australia","Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Electrophysiology Facility for Cell Phenotyping and Drug Discovery, IHMRI, Wollongong, NSW, Australia","institution_ids":["https://openalex.org/I4210091629"]},{"raw_affiliation_string":"Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW, Australia","institution_ids":["https://openalex.org/I204824540","https://openalex.org/I4210091629"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025386235","display_name":"David J. Adams","orcid":"https://orcid.org/0000-0002-7030-2288","observed_orcids":["https://orcid.org/0000-0002-7030-2288"]},"institutions":[{"id":"https://openalex.org/I204824540","display_name":"University of Wollongong","ror":"https://ror.org/00jtmb277","country_code":"AU","type":"education","lineage":["https://openalex.org/I204824540"]},{"id":"https://openalex.org/I4210091629","display_name":"Illawarra Health and Medical Research Institute","ror":"https://ror.org/00dt9qb91","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210091629"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"David J. Adams","raw_affiliation_strings":["Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW, Australia","institution_ids":["https://openalex.org/I204824540","https://openalex.org/I4210091629"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032114486","display_name":"MacDonald J. Christie","orcid":"https://orcid.org/0000-0002-0622-609X","observed_orcids":["https://orcid.org/0000-0002-0622-609X"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Macdonald J. Christie","raw_affiliation_strings":["Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I129604602"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5085347016"],"corresponding_institution_ids":["https://openalex.org/I204824540","https://openalex.org/I4210091629"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":0.3921,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.48811731,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"11","issue":null,"first_page":"633679","last_page":"633679"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.9169999957084656,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.9169999957084656,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11204","display_name":"Ion Channels and Receptors","score":0.03880000114440918,"subfield":{"id":"https://openalex.org/subfields/2809","display_name":"Sensory Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.03200000151991844,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/spider-venom-peptides","display_name":"spider venom peptides","score":0.7720000147819519},{"id":"https://openalex.org/keywords/high-voltage-activated-calcium-channels","display_name":"high-voltage-activated calcium channels","score":0.9010000228881836},{"id":"https://openalex.org/keywords/voltage-gated-calcium-channels","display_name":"voltage-gated calcium channels","score":0.7689999938011169},{"id":"https://openalex.org/keywords/dorsal-root-ganglion-neurons","display_name":"dorsal root ganglion neurons","score":0.8690000176429749},{"id":"https://openalex.org/keywords/antinociception","display_name":"antinociception","score":0.7940000295639038},{"id":"https://openalex.org/keywords/opioid-receptors","display_name":"opioid receptors","score":0.5479999780654907},{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.7390000224113464},{"id":"https://openalex.org/keywords/damgo","display_name":"DAMGO","score":0.8610000014305115},{"id":"https://openalex.org/keywords/naloxone","display_name":"naloxone","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cav2-2","display_name":"CaV2.2","score":0.7770000100135803},{"id":"https://openalex.org/keywords/voltage-dependent-inactivation","display_name":"voltage-dependent inactivation","score":0.8019999861717224},{"id":"https://openalex.org/keywords/nociception","display_name":"nociception","score":0.6050000190734863},{"id":"https://openalex.org/keywords/opioid-analgesia","display_name":"opioid analgesia","score":0.41600000858306885}],"concepts":[{"id":"https://openalex.org/C2776401185","wikidata":"https://www.wikidata.org/wiki/Q5204254","display_name":"DAMGO","level":5,"score":0.721031129360199},{"id":"https://openalex.org/C2776281502","wikidata":"https://www.wikidata.org/wiki/Q1395415","display_name":"Dorsal root ganglion","level":3,"score":0.6398925185203552},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.563044548034668},{"id":"https://openalex.org/C18699975","wikidata":"https://www.wikidata.org/wiki/Q14905735","display_name":"Voltage-dependent calcium channel","level":3,"score":0.544281005859375},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5140751600265503},{"id":"https://openalex.org/C49773422","wikidata":"https://www.wikidata.org/wiki/Q4859345","display_name":"Pertussis toxin","level":4,"score":0.4958685338497162},{"id":"https://openalex.org/C50952357","wikidata":"https://www.wikidata.org/wiki/Q424960","display_name":"Sodium channel","level":3,"score":0.48354291915893555},{"id":"https://openalex.org/C147944092","wikidata":"https://www.wikidata.org/wiki/Q176366","display_name":"Patch clamp","level":3,"score":0.45524781942367554},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.4291468858718872},{"id":"https://openalex.org/C15358309","wikidata":"https://www.wikidata.org/wiki/Q24780345","display_name":"Spider toxin","level":4,"score":0.428567111492157},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4104357063770294},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.40904372930526733},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.3690437078475952},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.3384607434272766},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.30868881940841675},{"id":"https://openalex.org/C2779886867","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opioid receptor","level":4,"score":0.2873653471469879},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.23440220952033997},{"id":"https://openalex.org/C537181965","wikidata":"https://www.wikidata.org/wiki/Q658","display_name":"Sodium","level":2,"score":0.17655536532402039},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1701015830039978},{"id":"https://openalex.org/C80631254","wikidata":"https://www.wikidata.org/wiki/Q407438","display_name":"G protein","level":3,"score":0.16902807354927063},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16703492403030396},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12806588411331177},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.0838286280632019},{"id":"https://openalex.org/C94487597","wikidata":"https://www.wikidata.org/wiki/Q11101","display_name":"Sensory system","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.3389/fphar.2020.633679","doi":"https://doi.org/10.3389/fphar.2020.633679","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2020.633679","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2020.633679/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7875911","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7875911","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:33584315","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33584315","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:ro.uow.edu.au:test2021-1675","doi":null,"is_oa":false,"landing_page_url":"https://ro.uow.edu.au/test2021/666","pdf_url":null,"source":{"id":"https://openalex.org/S4306400510","display_name":"Research Online (University of Wollongong)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I204824540","host_organization_name":"University of Wollongong","host_organization_lineage":["https://openalex.org/I204824540"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Test Series for Scopus Harvesting 2021","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:08d20781b23a4efa8934120da34df326","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/08d20781b23a4efa8934120da34df326","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 11 (2021)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/27818583","doi":null,"is_oa":false,"landing_page_url":"https://figshare.com/articles/journal_contribution/Spider_Venom_Peptide_Pn3a_Inhibition_of_Primary_Afferent_High_Voltage-Activated_Calcium_Channels/27818583","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.3389/fphar.2020.633679","doi":"https://doi.org/10.3389/fphar.2020.633679","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2020.633679","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2020.633679/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5948906002","display_name":"Ion channel modulators of pain pathways","funder_award_id":"1072113","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320320471","display_name":"Rebecca L. Cooper Medical Research Foundation","ror":"https://ror.org/038mte443"},{"id":"https://openalex.org/F4320321589","display_name":"Fondation pour la Recherche M\u00e9dicale","ror":"https://ror.org/04w6kn183"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"},{"id":"https://openalex.org/F4320336174","display_name":"Institute for Molecular Bioscience, University Of Queensland","ror":"https://ror.org/018kjjj71"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3128097311.pdf","grobid_xml":"https://content.openalex.org/works/W3128097311.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W1511198581","https://openalex.org/W1600100013","https://openalex.org/W1601641315","https://openalex.org/W1791194461","https://openalex.org/W2006356077","https://openalex.org/W2008969728","https://openalex.org/W2011272321","https://openalex.org/W2020872723","https://openalex.org/W2031242415","https://openalex.org/W2037088983","https://openalex.org/W2047458497","https://openalex.org/W2056029104","https://openalex.org/W2063048269","https://openalex.org/W2085922050","https://openalex.org/W2090510137","https://openalex.org/W2101745948","https://openalex.org/W2108114952","https://openalex.org/W2111569503","https://openalex.org/W2111771803","https://openalex.org/W2122467599","https://openalex.org/W2127494940","https://openalex.org/W2132856129","https://openalex.org/W2145251958","https://openalex.org/W2148188575","https://openalex.org/W2148913597","https://openalex.org/W2155765257","https://openalex.org/W2158602841","https://openalex.org/W2185789127","https://openalex.org/W2325233772","https://openalex.org/W2558485095","https://openalex.org/W2577015886","https://openalex.org/W2588377216","https://openalex.org/W2616235439","https://openalex.org/W2896902447","https://openalex.org/W2923079441","https://openalex.org/W2928010947","https://openalex.org/W2934109917","https://openalex.org/W2970061330","https://openalex.org/W2991162290","https://openalex.org/W3008736054","https://openalex.org/W3012130527","https://openalex.org/W3105697612","https://openalex.org/W4296928814"],"related_works":["https://openalex.org/W2577015886","https://openalex.org/W2077116506","https://openalex.org/W2291652420","https://openalex.org/W2168903024","https://openalex.org/W3008736054","https://openalex.org/W2892346250","https://openalex.org/W2018327597","https://openalex.org/W4324017530","https://openalex.org/W4396760036","https://openalex.org/W4386476172"],"abstract_inverted_index":{"Despite":[0],"potently":[1],"inhibiting":[2],"the":[3,53,139,167],"nociceptive":[4,65],"voltage-gated":[5,43],"sodium":[6],"(Nav)":[7],"channel,":[8],"Nav1.7,":[9],"\u00b5-theraphotoxin":[10],"Pn3a":[11,87,124,149,165,180,187,215,238,246],"is":[12],"antinociceptive":[13,197,224],"only":[14],"upon":[15],"co-administration":[16],"with":[17,110,166],"sub-therapeutic":[18,218],"opioid":[19,75],"agonists,":[20],"or":[21,240],"by":[22,32,74,123,210,244],"itself":[23],"at":[24,194,227,236],"doses":[25,216],">3,000-fold":[26],"greater":[27],"than":[28],"its":[29],"Nav1.7":[30],"IC50":[31],"a":[33,116],"yet":[34],"undefined":[35],"mechanism.":[36],"Nav":[37],"channels":[38,51,175],"are":[39,72],"structurally":[40],"related":[41],"to":[42],"calcium":[44,57],"(Cav)":[45],"channels,":[46],"Cav1":[47],"and":[48,71,97,103,150,181,190,217,247],"Cav2.":[49],"These":[50],"mediate":[52],"high":[54,237],"voltage-activated":[55],"(HVA)":[56],"currents":[58,106],"(ICa)":[59],"that":[60,86,146,186],"orchestrate":[61],"synaptic":[62],"transmission":[63],"in":[64,107,138,155,159,199,229],"dorsal":[66],"root":[67],"ganglion":[68],"(DRG)":[69],"neurons":[70,161],"fine-tuned":[73],"receptor":[76],"(OR)":[77],"activity.":[78],"Using":[79],"whole-cell":[80],"patch":[81],"clamp":[82],"recording,":[83],"we":[84],"found":[85],"(10":[88],"\u00b5M)":[89,130],"inhibits":[90,188],"\u223c55%":[91],"of":[92,99,113,142,148,164,179,207,213,234],"rat":[93],"DRG":[94,118,160,208],"neuron":[95],"HVA-ICa":[96,157,209,235],"60\u201380%":[98],"Cav1.2,":[100],"Cav1.3,":[101],"Cav2.1,":[102],"Cav2.2":[104,121],"mediated":[105],"HEK293":[108],"cells,":[109],"no":[111],"inhibition":[112,122,158,233,243],"Cav2.3.":[114],"As":[115],"major":[117],"ICa":[119],"component,":[120],"(IC50":[125],"=":[126],"3.71":[127],"\u00b1":[128],"0.21":[129],"arises":[131],"from":[132,231],"an":[133],"18":[134],"mV":[135],"hyperpolarizing":[136],"shift":[137],"voltage":[140],"dependence":[141],"inactivation.":[143],"We":[144,183,203,221],"observed":[145],"co-application":[147,163],"\u00b5-OR":[151],"agonist":[152],"DAMGO":[153],"results":[154],"enhanced":[156],"whereas":[162],"OR":[168,249],"antagonist":[169],"naloxone":[170],"does":[171],"not,":[172],"underscoring":[173],"HVA":[174,192],"as":[176],"shared":[177],"targets":[178],"opioids.":[182],"provide":[184],"evidence":[185],"native":[189],"recombinant":[191],"Cavs":[193],"previously":[195],"reportedly":[196],"concentrations":[198],"animal":[200],"pain":[201],"models.":[202],"show":[204],"additive":[205,242],"modulation":[206],"sequential":[211],"application":[212],"low":[214,245],"opioids":[219],"ligands.":[220],"propose":[222],"Pn3a's":[223],"effects":[225],"result,":[226],"least":[228],"part,":[230],"direct":[232],"doses,":[239],"through":[241],"mild":[248],"activation.":[250]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-02-15T00:00:00"}